Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails
2018 · Stem Cell Research & Therapy · 109 citations
https://doi.org/10.1186/s13287-018-0794-4
Y
Yan Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
2.1K
Citations
28
h-index
43
i10-index
Yan Xu is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Pluripotent Stem Cells Research & CRISPR and Genetic Engineering & RNA modifications and cancer. The author has an h-index of 28, co-authored 88 publications.
ORCID: 0000-0001-5653-291XPapers by this author
worksTargeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation
2020 · Journal of Hepatology · 75 citations
https://doi.org/10.1016/j.jhep.2020.11.016
Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a
2022 · Nature Communications · 61 citations
https://doi.org/10.1038/s41467-022-32169-4
The Hypoxia-inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-induced Toxicity
2013 · Journal of Biological Chemistry · 57 citations
https://doi.org/10.1074/jbc.m113.538157
Low-dose PCB126 compromises circadian rhythms associated with disordered glucose and lipid metabolism in mice
2019 · Environment International · 40 citations
https://doi.org/10.1016/j.envint.2019.04.058
Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element
2011 · Oncogene · 37 citations
https://doi.org/10.1038/onc.2011.305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat